The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.

 
Web www.patentalert.com

< 2-(3-Aminoaryl)amino-4-aryl-thiazoles for the treatment of diseases

> Method for the enrichment and characterization of phosphorylated peptides or proteins
~ 00460